AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Roberts, E. A
Right arrow Articles by Sarkar, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, E. A
Right arrow Articles by Sarkar, B.
Agricola
Right arrow Articles by Roberts, E. A
Right arrow Articles by Sarkar, B.
American Journal of Clinical Nutrition, Vol. 88, No. 3, 851S-854S, September 2008
© 2008 American Society for Nutrition


Integrating Whole-Body Copper Metabolism in Health and Disease

Liver as a key organ in the supply, storage, and excretion of copper1,2,3,4

Eve A Roberts and Bibudhendra Sarkar

1 From the Genetics and Genome Biology Program (EAR) and Molecular Structure and Function Program (BS), Hospital for Sick Children Research Institute, and the Departments of Paediatrics (EAR), Medicine (EAR), Pharmacology (EAR), and Biochemistry (BS), University of Toronto, Toronto, ON, Canada

ABSTRACT

The liver plays an important role in the disposition of copper. Most dietary copper passes through the liver where it can be used for protein and energy production or excreted through the biliary route. Because copper is a prooxidant, its intracellular handling is tightly managed. In Wilson disease, in which synthesis of ceruloplasmin and biliary excretion of copper are defective, copper accumulates in the liver and leads to progressive liver damage. The features of hepatic Wilson disease are highly variable. The spectrum of liver disease includes mild inflammation, fatty liver, an autoimmune disorder, and cirrhosis. Wilson disease thus resembles drug hepatotoxicity, and indeed it can be regarded as a prototypic example of endogenous hepatotoxicity. Biomarkers developed for detecting drug hepatotoxicity may be relevant to Wilson disease. Biomarkers developed through metalloproteomics, which for copper seeks to define a set of proteins that have copper-binding capacity, or through genomic studies may also be relevant to Wilson disease and other disorders of copper handling, whether copper is deficient or overloaded.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition